About Nova Eye Medical
Nova Eye Medical is a company based in Fremont (United States) founded in 1985. It operates as a Direct-to-Consumer (D2C), and Professional Services. Nova Eye Medical offers products and services including iTrack™ Advance, Molteno3®, and AlphaRET. Nova Eye Medical operates in a competitive market with competitors including iSTAR Medical, Ciliatech, LIQID Medical and Microt, among others.
- Headquarter Fremont, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nova Eye Medical Limited
-
Annual Revenue
$19.11 M (USD)25.47as on Jun 30, 2025
-
Net Profit
$-5.92 M (USD)-3.06as on Jun 30, 2025
-
EBITDA
$-4.39 M (USD)-12.44as on Jun 30, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nova Eye Medical
Nova Eye Medical is a publicly listed company on the ASX with ticker symbol EYE in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nova Eye Medical
Nova Eye Medical offers a comprehensive portfolio of products and services, including iTrack™ Advance, Molteno3®, and AlphaRET. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for treating open-angle glaucoma in adults.
Designed for glaucoma treatment in ophthalmic surgery.
Developed for advancing ophthalmic treatment solutions.
Funding Insights of Nova Eye Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Nova Eye Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nova Eye Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nova Eye Medical Comparisons
Competitors of Nova Eye Medical
Nova Eye Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iSTAR Medical, Ciliatech, LIQID Medical and Microt, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive glaucoma surgery implants are developed for open-angle treatment.
|
|
| domain | founded_year | HQ Location |
Hydrophilic hydrogel implants for glaucoma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Implantable devices for glaucoma fluid drainage are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for glaucoma treatment are developed by Microt.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nova Eye Medical
Frequently Asked Questions about Nova Eye Medical
When was Nova Eye Medical founded?
Nova Eye Medical was founded in 1985.
Where is Nova Eye Medical located?
Nova Eye Medical is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
What is the annual revenue of Nova Eye Medical?
Annual revenue of Nova Eye Medical is $19.11M as on Jun 30, 2025.
What does Nova Eye Medical do?
Nova Eye Medical is focused on designing, developing, manufacturing, and marketing proprietary glaucoma treatment technologies. The company operates within the healthcare sector, specifically targeting ophthalmic solutions. Products like iTrack Advance and Molteno3 are developed to advance clinical outcomes and improve patient quality of life. Their technologies are utilized by ophthalmologists globally to address open-angle glaucoma through innovative surgical techniques. Operations are supported by offices in Australia, the United States, New Zealand, and Germany.
Who are the top competitors of Nova Eye Medical?
Nova Eye Medical's top competitors include iSTAR Medical, Microt and LIQID Medical.
What products or services does Nova Eye Medical offer?
Nova Eye Medical offers iTrack™ Advance, Molteno3®, and AlphaRET.
Is Nova Eye Medical publicly traded?
Yes, Nova Eye Medical is publicly traded on ASX under the ticker symbol EYE.
What is Nova Eye Medical's ticker symbol?
The ticker symbol of Nova Eye Medical is EYE on ASX.